{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:28:26Z","timestamp":1795130906908,"version":"4.10.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030100"],"award-info":[{"award-number":["82030100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In the American population, the relationship between the triglyceride-glucose (TyG) index and TYG combined with indicators of obesity and cardiovascular disease (CVD) and its mortality has been less well studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included 11,937 adults from the National Health and Nutrition Examination Survey (NHANES) 2003\u20132018. Cox proportional hazards model, binary logistic regression analyses, restricted cubic spline (RCS), and receiver operating characteristic (ROC) were used to analyze the relationship between TyG and its combined obesity-related indicators and CVD and its mortality. Mediation analysis explored the mediating role of glycated hemoglobin and insulin in the above relationships.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this study, except for no significant association between TyG and CVD mortality, TyG, TyG-WC, TyG-WHtR, and TyG-BMI were significantly and positively associated with CVD and CVD mortality. TyG-WHtR is the strongest predictor of CVD mortality (HR 1.66, 95% CI 1.21\u20132.29). The TyG index correlated better with the risk of coronary heart disease (OR 2.52, 95% CI 1.66\u20133.83). TyG-WC correlated best with total CVD (OR 2.37, 95% CI 1.77\u20133.17), congestive heart failure (OR 2.14, 95% CI 1.31\u20133.51), and angina pectoris (OR 2.38, 95% CI 1.43\u20133.97). TyG-WHtR correlated best with myocardial infarction (OR 2.24, 95% CI 1.45\u20133.44). RCS analyses showed that most of the above relationships were linear (P-overall\u2009&lt;\u20090.0001, P-nonlinear\u2009&gt;\u20090.05). Otherwise, ROC curves showed that TyG-WHtR and TyG-WC had more robust diagnostic efficacy than TyG. In mediation analyses, glycated hemoglobin mediated in all the above relationships and insulin-mediated in partial relationships.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TyG-WC and TyG-WtHR enhance CVD mortality prediction, diagnostic efficacy of CVD and its mortality, and correlation with some CVD over and above the current hottest TyG. TyG-WC and TyG-WtHR are expected to become more effective metrics for identifying populations at early risk of cardiovascular disease and improve risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-02115-9","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T09:01:43Z","timestamp":1704531703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":612,"title":["The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018"],"prefix":"10.1186","volume":"23","author":[{"given":"Keke","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"issue":"25","key":"2115_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk. J Am Coll Cardiol. 2022;80(25):2361\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"2115_CR2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"2115_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82053-2","author":"J Lee","year":"2021","unstructured":"Lee J, Kim B, Kim W, Ahn C, Choi HY, Kim JG, Kim J, Shin H, Kang JG, Moon S. Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-82053-2.","journal-title":"Sci Rep"},{"issue":"4","key":"2115_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"3","key":"2115_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2337\/dc08-1195","volume":"32","author":"K Faerch","year":"2009","unstructured":"Faerch K, Vaag A, Holst J, Hansen T, J\u00f8rgensen T, Borch-Johnsen K. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care. 2009;32(3):439\u201344.","journal-title":"Diabetes Care"},{"key":"2115_CR6","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"R DeFronzo","year":"2015","unstructured":"DeFronzo R, Ferrannini E, Groop L, Henry R, Herman W, Holst J, Hu F, Kahn C, Raz I, Shulman G, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2115_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"B Kahn","year":"2000","unstructured":"Kahn B, Flier J. Obesity and insulin resistance. J Clin Investig. 2000;106(4):473\u201381.","journal-title":"J Clin Investig"},{"key":"2115_CR8","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"M Hill","year":"2021","unstructured":"Hill M, Yang Y, Zhang L, Sun Z, Jia G, Parrish A, Sowers J. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metab Clin Exp. 2021;119:154766.","journal-title":"Metab Clin Exp"},{"issue":"5","key":"2115_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"K Bornfeldt","year":"2011","unstructured":"Bornfeldt K, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575\u201385.","journal-title":"Cell Metab"},{"issue":"3","key":"2115_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jama.294.3.334","volume":"294","author":"E Ingelsson","year":"2005","unstructured":"Ingelsson E, Sundstr\u00f6m J, Arnl\u00f6v J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. JAMA. 2005;294(3):334\u201341.","journal-title":"JAMA"},{"issue":"1","key":"2115_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12933-023-01906-4","volume":"22","author":"S Liang","year":"2023","unstructured":"Liang S, Wang C, Zhang J, Liu Z, Bai Y, Chen Z, Huang H, He Y. Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis. Cardiovasc Diabetol. 2023;22(1):170.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2115_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-022-01576-8","volume":"21","author":"Z Wu","year":"2022","unstructured":"Wu Z, Liu L, Wang W, Cui H, Zhang Y, Xu J, Zhang W, Zheng T, Yang J. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):142.","journal-title":"Cardiovasc Diabetol"},{"key":"2115_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01511-x","author":"L-C Tao","year":"2022","unstructured":"Tao L-C, Xu J-N, Wang T-T, Hua F, Li J-J. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022. https:\/\/doi.org\/10.1186\/s12933-022-01511-x.","journal-title":"Cardiovasc Diabetol"},{"key":"2115_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01268-9","author":"X Ding","year":"2021","unstructured":"Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride\u2013glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021. https:\/\/doi.org\/10.1186\/s12933-021-01268-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2115_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","volume":"20","author":"D Huang","year":"2023","unstructured":"Huang D, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol. 2023;20(1):37\u201349.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"13","key":"2115_CR16","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jacc.2018.08.1037","volume":"72","author":"C Lavie","year":"2018","unstructured":"Lavie C, Laddu D, Arena R, Ortega F, Alpert M, Kushner R. Healthy weight and obesity prevention: JACC health promotion series. J Am Coll Cardiol. 2018;72(13):1506\u201331.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2115_CR17","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.2337\/dc14-3084","volume":"38","author":"T Huang","year":"2015","unstructured":"Huang T, Qi Q, Zheng Y, Ley S, Manson J, Hu F, Qi L. Genetic predisposition to central obesity and risk of type 2 diabetes: two independent cohort studies. Diabetes Care. 2015;38(7):1306\u201311.","journal-title":"Diabetes Care"},{"key":"2115_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.0022","author":"SS Khan","year":"2018","unstructured":"Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, Sweis RN, Lloyd-Jones DM. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018. https:\/\/doi.org\/10.1001\/jamacardio.2018.0022.","journal-title":"JAMA Cardiol"},{"issue":"17","key":"2115_CR19","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/eurheartj\/ehy057","volume":"39","author":"S Iliodromiti","year":"2018","unstructured":"Iliodromiti S, Celis-Morales C, Lyall D, Anderson J, Gray S, Mackay D, Nelson S, Welsh P, Pell J, Gill J, et al. The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent. Eur Heart J. 2018;39(17):1514\u201320.","journal-title":"Eur Heart J"},{"issue":"9771","key":"2115_CR20","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(11)60105-0","volume":"377","author":"D Wormser","year":"2011","unstructured":"Wormser D, Kaptoge S, Di Angelantonio E, Wood A, Pennells L, Thompson A, Sarwar N, Kizer J, Lawlor D, Nordestgaard B, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085\u201395.","journal-title":"Lancet"},{"issue":"2","key":"2115_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s42000-023-00448-4","volume":"22","author":"S Yan","year":"2023","unstructured":"Yan S, Wang D, Jia Y. Comparison of insulin resistance-associated parameters in US adults: a cross-sectional study. Hormones. 2023;22(2):331\u201341.","journal-title":"Hormones"},{"issue":"3","key":"2115_CR22","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","volume":"14","author":"J Lim","year":"2019","unstructured":"Lim J, Kim J, Koo S, Kwon G. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007\u20132010 Korean national health and nutrition examination survey. PLoS ONE. 2019;14(3):e0212963.","journal-title":"PLoS ONE"},{"issue":"1","key":"2115_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13098-022-00855-4","volume":"14","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang T, He S, Jia S, Zhang Z, Ye R, Yang X, Chen X. Association of metabolic syndrome with TyG index and TyG-related parameters in an urban Chinese population: a 15-year prospective study. Diabetol Metab Syndr. 2022;14(1):84.","journal-title":"Diabetol Metab Syndr"},{"key":"2115_CR24","doi-asserted-by":"publisher","first-page":"1001844","DOI":"10.3389\/fendo.2022.1001844","volume":"13","author":"S Zhou","year":"2022","unstructured":"Zhou S, Yu Y, Zhang Z, Ma L, Wang C, Yang M, Cheng X, Liu T, Sun R, Chen Y. Association of obesity, triglyceride-glucose and its derivatives index with risk of hyperuricemia among college students in Qingdao, China. Front Endocrinol. 2022;13:1001844.","journal-title":"Front Endocrinol"},{"key":"2115_CR25","doi-asserted-by":"publisher","first-page":"949831","DOI":"10.3389\/fendo.2022.949831","volume":"13","author":"W Xuan","year":"2022","unstructured":"Xuan W, Liu D, Zhong J, Luo H, Zhang X. Impacts of triglyceride glucose-waist to height ratio on diabetes incidence: a secondary analysis of a population-based longitudinal data. Front Endocrinol. 2022;13:949831.","journal-title":"Front Endocrinol"},{"key":"2115_CR26","doi-asserted-by":"publisher","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, Xu J, Li M, Gao Y. Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front Endocrinol. 2022;13:951689.","journal-title":"Front Endocrinol"},{"issue":"3","key":"2115_CR27","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"L Er","year":"2016","unstructured":"Er L, Wu S, Chou H, Hsu L, Teng M, Sun Y, Ko Y. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3):e0149731.","journal-title":"PLoS ONE"},{"issue":"1","key":"2115_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-023-01794-8","volume":"22","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):75.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"2115_CR29","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.2337\/dc22-0462","volume":"45","author":"W Hou","year":"2022","unstructured":"Hou W, Han T, Sun X, Chen Y, Xu J, Wang Y, Yang X, Jiang W, Sun C. Relationship between carbohydrate intake (quantity, quality, and time eaten) and mortality (total, cardiovascular, and diabetes): assessment of 2003\u20132014 national health and nutrition examination survey participants. Diabetes Care. 2022;45(12):3024\u201331.","journal-title":"Diabetes Care"},{"key":"2115_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13098-018-0376-8","volume":"10","author":"S Khan","year":"2018","unstructured":"Khan S, Sobia F, Niazi N, Manzoor S, Fazal N, Ahmad F. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr. 2018;10:74.","journal-title":"Diabetol Metab Syndr"},{"key":"2115_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12933-014-0146-3","volume":"13","author":"T Du","year":"2014","unstructured":"Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13:146.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2115_CR32","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda L, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala M, Hern\u00e1ndez-Gonz\u00e1lez S, Jacques-Camarena O, Rodr\u00edguez-Mor\u00e1n M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"2115_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01762-2","author":"B Che","year":"2023","unstructured":"Che B, Zhong C, Zhang R, Pu L, Zhao T, Zhang Y, Han L. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023. https:\/\/doi.org\/10.1186\/s12933-023-01762-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2115_CR34","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2337\/dc18-1920","volume":"42","author":"K Park","year":"2019","unstructured":"Park K, Ahn C, Lee S, Kang S, Nam J, Lee B, Kim J, Park J. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569\u201373.","journal-title":"Diabetes Care"},{"key":"2115_CR35","doi-asserted-by":"publisher","first-page":"994329","DOI":"10.3389\/fcvm.2022.994329","volume":"9","author":"H Qu","year":"2022","unstructured":"Qu H, Long L, Chen L, Wu H, Fu C, Zhang S. Triglyceride-glucose index and estimated 10-year risk of a first hard cardiovascular event. Front Cardiovasc Med. 2022;9:994329.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2115_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"key":"2115_CR37","doi-asserted-by":"publisher","first-page":"628109","DOI":"10.3389\/fcvm.2020.628109","volume":"7","author":"X Liu","year":"2020","unstructured":"Liu X, He G, Lo K, Huang Y, Feng Y. The triglyceride-glucose index, an insulin resistance marker, was non-linear associated with all-cause and cardiovascular mortality in the general population. Front Cardiovasc Med. 2020;7:628109.","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"2115_CR38","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/gerona\/glr098","volume":"66","author":"J Kizer","year":"2011","unstructured":"Kizer J, Arnold A, Jenny N, Cushman M, Strotmeyer E, Ives D, Ding J, Kritchevsky S, Chaves P, Hirsch C, et al. Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the cardiovascular health study all stars study. J Gerontol A Biol Sci Med Sci. 2011;66(10):1100\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"11","key":"2115_CR39","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1089\/ars.2014.5941","volume":"21","author":"A Ludin","year":"2014","unstructured":"Ludin A, Gur-Cohen S, Golan K, Kaufmann K, Itkin T, Medaglia C, Lu X, Ledergor G, Kollet O, Lapidot T. Reactive oxygen species regulate hematopoietic stem cell self-renewal, migration and development, as well as their bone marrow microenvironment. Antioxid Redox Signal. 2014;21(11):1605\u201319.","journal-title":"Antioxid Redox Signal"},{"key":"2115_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010092","author":"Y Cho","year":"2020","unstructured":"Cho Y, Lee J, Kim H, Kim E, Lee M, Yang D, Kang J, Jung C, Park J, Kim H, et al. Triglyceride glucose-waist circumference better predicts coronary calcium progression compared with other indices of insulin resistance: a longitudinal observational study. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm10010092.","journal-title":"J Clin Med"},{"issue":"21","key":"2115_CR41","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","volume":"53","author":"C Lavie","year":"2009","unstructured":"Lavie C, Milani R, Ventura H. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"2115_CR42","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1001\/jama.280.21.1843","volume":"280","author":"K Rexrode","year":"1998","unstructured":"Rexrode K, Carey V, Hennekens C, Walters E, Colditz G, Stampfer M, Willett W, Manson J. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280(21):1843\u20138.","journal-title":"JAMA"},{"key":"2115_CR43","doi-asserted-by":"publisher","first-page":"110199","DOI":"10.1016\/j.diabres.2022.110199","volume":"195","author":"H Wang","year":"2023","unstructured":"Wang H, He S, Wang J, An Y, Wang X, Li G, Gong Q. Hyperinsulinemia and plasma glucose level independently associated with all-cause and cardiovascular mortality in Chinese people without diabetes-A post-hoc analysis of the 30-year follow-up of Da Qing diabetes and IGT study. Diabetes Res Clin Pract. 2023;195:110199.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2115_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-020-01121-5","volume":"19","author":"N Barzegar","year":"2020","unstructured":"Barzegar N, Tohidi M, Hasheminia M, Azizi F, Hadaegh F. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study. Cardiovasc Diabetol. 2020;19(1):155.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2115_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12933-022-01658-7","volume":"21","author":"X Li","year":"2022","unstructured":"Li X, Chan J, Guan B, Peng S, Wu X, Lu X, Zhou J, Hui J, Lee Y, Satti D, et al. Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a Mendelian randomization analysis. Cardiovasc Diabetol. 2022;21(1):229.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2115_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/eci.12583","volume":"46","author":"L S\u00e1nchez-\u00cd\u00f1igo","year":"2016","unstructured":"S\u00e1nchez-\u00cd\u00f1igo L, Navarro-Gonz\u00e1lez D, Fern\u00e1ndez-Montero A, Pastrana-Delgado J, Mart\u00ednez J. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189\u201397.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2115_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12933-022-01694-3","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L, Wu Z, Zhuang Y, Zhang Y, Cui H, Lu F, Peng J, Yang J. Association of triglyceride-glucose index and traditional risk factors with cardiovascular disease among non-diabetic population: a 10-year prospective cohort study. Cardiovasc Diabetol. 2022;21(1):256.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"2115_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrendo.2014.29","volume":"10","author":"M Laakso","year":"2014","unstructured":"Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293\u2013302.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2115_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12933-021-01413-4","volume":"20","author":"C Sinning","year":"2021","unstructured":"Sinning C, Makarova N, V\u00f6lzke H, Schnabel R, Ojeda F, D\u00f6rr M, Felix S, Koenig W, Peters A, Rathmann W, et al. Association of glycated hemoglobin A levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (biomarker for cardiovascular risk assessment in Europe) consortium. Cardiovasc Diabetol. 2021;20(1):223.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"2115_CR50","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa0908359","volume":"362","author":"E Selvin","year":"2010","unstructured":"Selvin E, Steffes M, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati F. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800\u201311.","journal-title":"N Engl J Med"},{"issue":"2","key":"2115_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2337\/diacare.2.2.131","volume":"2","author":"K Py\u00f6r\u00e4la","year":"1979","unstructured":"Py\u00f6r\u00e4la K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2(2):131\u201341.","journal-title":"Diabetes Care"},{"issue":"24","key":"2115_CR52","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1001\/jama.279.24.1955","volume":"279","author":"B Lamarche","year":"1998","unstructured":"Lamarche B, Tchernof A, Mauri\u00e8ge P, Cantin B, Dagenais G, Lupien P, Despr\u00e9s J. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 1998;279(24):1955\u201361.","journal-title":"JAMA"},{"issue":"25","key":"2115_CR53","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/S0024-3205(99)00537-8","volume":"65","author":"A Sinha","year":"1999","unstructured":"Sinha A, Bhattacharya S, Acharya K, Mazumder S. Stimulation of nitric oxide synthesis and protective role of insulin in acute thrombosis in vivo. Life Sci. 1999;65(25):2687\u201396.","journal-title":"Life Sci"},{"key":"2115_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0300-483X(00)00275-4","volume":"155","author":"L Xi","year":"2000","unstructured":"Xi L, Kukreja R. Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction. Toxicology. 2000;155:37\u201344.","journal-title":"Toxicology"},{"issue":"3","key":"2115_CR55","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/phrs.2001.0944","volume":"45","author":"A Yazar","year":"2002","unstructured":"Yazar A, Polat G, Un I, Levent A, Kaygusuz A, B\u00fcy\u00fckaf\u015far K, \u00c7amdeviren H. Effects of glibenclamide, metformin and insulin on the incidence and latency of death by oubain-induced arrhythmias in mice. Pharmacol Res. 2002;45(3):183\u20137.","journal-title":"Pharmacol Res"},{"issue":"4","key":"2115_CR56","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1152\/physrev.00030.2020","volume":"101","author":"J Ren","year":"2021","unstructured":"Ren J, Wu N, Wang S, Sowers J, Zhang Y. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev. 2021;101(4):1745\u2013807.","journal-title":"Physiol Rev"},{"issue":"1","key":"2115_CR57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga F. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02115-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-02115-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02115-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T13:02:27Z","timestamp":1704805347000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-02115-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2115"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-02115-9","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that they had no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}